1. Home
  2. NVTS vs OCUL Comparison

NVTS vs OCUL Comparison

Compare NVTS & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navitas Semiconductor Corporation

NVTS

Navitas Semiconductor Corporation

HOLD

Current Price

$14.82

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$9.27

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVTS
OCUL
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
NVTS
OCUL
Price
$14.82
$9.27
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$6.68
$23.56
AVG Volume (30 Days)
28.8M
3.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,916,000.00
$1,990,000.00
Revenue This Year
N/A
$7.93
Revenue Next Year
$71.28
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$1.80
$6.23
52 Week High
$19.79
$16.44

Technical Indicators

Market Signals
Indicator
NVTS
OCUL
Relative Strength Index (RSI) 59.25 53.40
Support Level $7.05 $8.36
Resistance Level $17.79 $9.86
Average True Range (ATR) 1.60 0.50
MACD 0.58 0.07
Stochastic Oscillator 54.31 60.62

Price Performance

Historical Comparison
NVTS
OCUL

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components. Geographically, the company operates in Hong Kong, China, Europe, the United States, Rest of Asia, and Others. The majority of revenue is generated from Hong Kong.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: